AstraZeneca signed its first COVID-19 vaccine supply deal with a Chinese company, Kangtai Bio, on Thursday, opening up distribution to one of the world's most populous countries.
- AstraZeneca signed its first COVID-19 vaccine supply deal with a Chinese company, Kangtai Bio, on Thursday, opening up distribution to one of the world’s most populous countries.
The company has been granted protection from future product liability claims related to the vaccine by most of the countries with which it has so far struck supply agreements, a senior executive told Reuters. *According to Italy’s health ministry, an AZD1222 shot would cost about 2.5 euros per dose in Europe.*Costs in other regions have not been disclosed.*AstraZeneca’s CEO said good data has come in so far on the shot, after early-stage clinical trials showed it was safe and produced an immune response.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Coronavirus updates: US clinches deal with Johnson & Johnson for potential vaccineCORONAVIRUS LATEST: — NYC to begin checkpoints enforcing state quarantine orders —U.S. clinches deal with Johnson & Johnson for potential vaccine — Chicago Public Schools will start with all-remote learning
Weiterlesen »
Factbox: Coronavirus in U.S. Congress: 15 members have tested or been presumed positiveAt least 15 members of the U.S. House of Representatives and Senate - eight Republicans and seven Democrats - have tested positive or are presumed to have had COVID-19 since the novel coronavirus pandemic began earlier this year, with Representative Rodney Davis becoming the latest on Wednesday.
Weiterlesen »
Novavax's coronavirus vaccine generates promising immune response in early trial, data showsNovavax's potential vaccine to prevent Covid-19 generated a promising immune response in an early-stage clinical trial, the U.S.-based biotech firm announced Tuesday.
Weiterlesen »
Novavax coronavirus vaccine induces immune response in small studyMaryland-based biotechnology company Novavax said its experimental COVID-19 vaccine produced antibodies against the novel coronavirus and appears to be safe, according to an early stage study
Weiterlesen »